Showing results (591-600 of 779) with videos related to
Sort By:
Pageof 78
BMJ Case Reports|July 10, 2015
Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for managementMitri Khoury, Geok Choo Sim, Michiko Harao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized studyM Valdivieso, M A Burgess, M S Ewer, et al.Cancer|April 22, 2006
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rulesKenneth V I Rolston, Ellen F Manzullo, Linda S Elting, et al.Cancer|June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcomaM L Meistrich, S P Chawla, M F Da Cunha, et al.Cancer Treatment Reports|May 1, 1979
High-dose methotrexate for advanced breast cancerH Y Yap, G R Blumenschein, B S Yap, et al.Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.Melanoma Research|December 22, 1999
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastasesO Eton, M East, S S Legha, et al.International Journal of Radiation Oncology, Biology, Physics|September 25, 2001
Epithelioid sarcoma: results of conservative surgery and radiotherapyM D Callister, M T Ballo, P W Pisters, et al.Cancer|November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanomaA Buzaid, S S Legha, C M Balch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumorsAung Naing, Patricia LoRusso, Siqing Fu, et al.Pageof 78